Curis to Present at the Oppenheimer 23rd Annual Healthcare Conference

[at noodls] – LEXINGTON, Mass., Dec. 6, 2012 (GLOBE NEWSWIRE) — Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the … more

View todays social media effects on CRIS

View the latest stocks trending across Twitter. Click to view dashboard

See who Curis is hiring next, click here to view